Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) CEO David Alan Campbell sold 8,072 shares of the business’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $13.73, for a total value of $110,828.56. Following the completion of the transaction, the chief executive officer directly owned 284,982 […]

Abeona Therapeutics Inc. (NASDAQ:ABEO – Get Free Report) CEO Vishwas Seshadri sold 25,000 shares of the firm’s stock in a transaction dated Monday, December 29th. The shares were sold at an average price of $5.31, for a total transaction of $132,750.00. Following the transaction, the chief executive officer directly owned 1,164,818 shares in the company, […]